Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar repair following LPS-induced injury requires cell-ECM interactions
Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa
Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa
View: Text | PDF
Research Article Cell biology Pulmonology

Alveolar repair following LPS-induced injury requires cell-ECM interactions

  • Text
  • PDF
Abstract

During alveolar repair, alveolar type 2 (AT2) epithelial cell progenitors rapidly proliferate and differentiate into flat AT1 epithelial cells. Failure of normal alveolar repair mechanisms can lead to loss of alveolar structure (emphysema) or development of fibrosis, depending on the type and severity of injury. To test if β1-containing integrins are required during repair following acute injury, we administered E. coli lipopolysaccharide (LPS) by intratracheal injection to mice with a postdevelopmental deletion of β1 integrin in AT2 cells. While control mice recovered from LPS injury without structural abnormalities, β1-deficient mice had more severe inflammation and developed emphysema. In addition, recovering alveoli were repopulated with an abundance of rounded epithelial cells coexpressing AT2 epithelial, AT1 epithelial, and mixed intermediate cell state markers, with few mature type 1 cells. AT2 cells deficient in β1 showed persistently increased proliferation after injury, which was blocked by inhibiting NF-κB activation in these cells. Lineage tracing experiments revealed that β1-deficient AT2 cells failed to differentiate into mature AT1 epithelial cells. Together, these findings demonstrate that functional alveolar repair after injury with terminal alveolar epithelial differentiation requires β1-containing integrins.

Authors

Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa

×

Figure 6

During alveolar repair, β1 integrin regulates actin localization and RhoA GTPase activation.

Options: View larger image (or click on image) Download as PowerPoint
During alveolar repair, β1 integrin regulates actin localization and Rho...
(A) Surface rendering high-power images of pro–SP-C–immunostained, thick, frozen sections from day 7 (D7) LPS-treated β1fl/fl and β1AT2-KO lungs. (B) High-power images of thick, frozen sections from D7 LPS-treated β1fl/fl and β1AT2-KO lungs immunostained for pro–SP-C (green) with phalloidin F-actin probe (magenta); arrows indicate areas of actin-rich lateral protrusions. (C) Area of pro–SP-C+CD68– AT2 cells from D7 LPS-treated β1fl/fl and β1AT2-KO mice (46.8 ± 2.0 μm2 in β1fl/fl lungs compared with 69.6 ± 2.8 μm2 in β1AT2-KO lungs, n = 6 mice/group, ≥40 cells measured/mouse imaged from 5 sections, 2-tailed t test, P < 0.0001). (D) Roundness score calculated from pro–SP-C+CD68– cells from D7 LPS-treated β1fl/fl and β1AT2-KO mice (38–60 cells measured/mouse from 5 sections, n = 6 mice/group, 2-tailed t test comparing genotypes, P = 0.0009). (E) High-power images of frozen sections prepared at D7 after LPS β1fl/fl and β1AT2-KO lungs immunostained for pro–SP-C (gold) with JLA20 (cyan) and phalloidin (magenta) probes applied to detect G-actin and F-actin, respectively. Membrane localization of G-actin denoted by arrows and F-actin by arrowheads. (F and G) Quantification of JLA20 (F) and phalloidin (G) expression in pro–SP-C+ AT2 cells in β1fl/fl and β1AT2-KO lungs D7 after LPS (n = 5–6 mice/group, 10 sections/mouse, 2-tailed t test with P = 0.0088 for JLA20 and P = 0.0482 for phalloidin). (H) Representative high-power images from D7 LPS-treated β1fl/fl and β1AT2-KO lungs immunostained for ezrin (cyan) with AT2 cells identified by RNA in situ hybridization for Sftpc (gold). Arrows indicate ezrin expression localized to lateral extensions in β1fl/fl AT2 cells, whereas diffuse, nonfocal ezrin expression along the cell membrane is seen in β1AT2-KO AT2 cells. * P < 0.05. Scale bar = 5 μm for A, B, and E; scale bar = 25 μm for panels in H.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts